TerrAscend to Host 2023 Investor Day on October 13th at The Toronto Stock Exchange
TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North...
News
Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Joint Fixation System
Carlsbad, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a...
Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference
-- Presentation to educate on Portable Neuromodulation Stimulator (PoNS®) Therapy, highlighting the differentiation from other neuromodulation technologies, and the science...
Joni and Friends Partners with the State Fair of Texas for Sensory-Friendly Morning
Wednesday, October 4th, 10:00 A.M. - 1:00 P.M.DALLAS, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Joni and Friends, a global non-profit...
It’s Back to School Across Ontario and Jack.org Has Launched a New Resource
Jack.org launches the Educator Hub, a new resource to support teachers in bringing vital mental health education to their students...
Spectral Medical Supports World Sepsis Day
World Sepsis Day is Today, September 13, 2023TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
- Introduction of New CEO Cynthia Pussinen and Recently Appointed Chief Business Officer, Dr. Modestus Obochi, on September 15, 2023...
Culture Biosciences Appoints Darcy Birse as Chief Commercial Officer
The life science and biotech commercial veteran will lead the company's growth strategy Darcy Birse - Chief Commercial Officer, Culture...
Arch Therapeutics Provides AC5® Commercialization Update
Orders and Paid Claims Increasing Since Rollout of Reimbursement CodeFRAMINGHAM, Mass., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc....
InvestmentPitch Media Video Discusses Reliq Health’s Signing of Significant New Contract with a Leading US healthcare Company with 75 Locations in 8 States
VANCOUVER, British Columbia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global...
Immuron achieves record monthly Travelan® sales
Highlights: Record monthly Travelan® salesAustralian sales of A$1.18 M in August 2023 (7984% increase on August 2022 sales)MELBOURNE, Australia, Sept....
Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve
COPENHAGEN, Denmark, September 13, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded another contract...
Philips extends its mobile C-arm range with Zenition 30, alleviating staff shortages by empowering surgeons with greater personalization and control
Philips Zenition 30 in use Philips Zenition 30 product photo September 13, 2023 Offering surgeons greater flexibility, control, and personalization...
Myricx Expands its Leadership Team with the Appointment of Dr. Robert McLeod as VP Clinical Development
LONDON, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development...
Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advanced Adenoma Sensitivity of 81%
Multiple novel mRNA biomarkers identified for potential integration into pivotal FDA PMA clinical trial (ReconAAsense) BERKELEY, Calif. and MAINZ, Germany,...
Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval
UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapyHighly experienced team ready to support...
Neuroscience Center in Sweden Orders Nexstim NBS 5 System
Press release, Helsinki, 13 September 2023 at 10 AM (EEST) Neuroscience Center in Sweden Orders Nexstim NBS 5 System Nexstim...
Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update
The total operating revenues amounted to $7.9M and increased by 131% compared to H1 2022.Updated clinical and preclinical data on...
Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease
Roche Venture Fund joins existing major investors Epidarex Capital, Sofinnova Partners and BioGeneration VenturesSeptember 13, 2023: Glasgow, Scotland – Mironid,...
Novo Nordisk conducts a two-for-one stock split
Bagsværd, Denmark, 13 September 2023 – As communicated on 10 August 2023 in connection with the release of Novo Nordisk's...